Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Nagase

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Asia Pacific Allergy|May 16, 2020
Preface to the Proceedings of the 33rd Workshop on Eosinophils in Allergy and Related Diseases 2019 (WEA 2019)Hiroyuki Nagase
Allergology International : Official Journal of the Japanese Society of Allergology|January 21, 2023
Rapid progress in molecular targeted therapy for allergic diseasesHiroyuki Nagase
Arerugi = [Allergy]|May 21, 2019
[MOLECULAR TARGETED THERAPY FOR ASTHMA: NON-TYPE 2 INFLAMMATION AND TOLL-LIKE RECEPTOR SIGNALING]Hiroyuki Nagase
Allergology International : Official Journal of the Japanese Society of Allergology|March 18, 2019
Severe asthma in JapanHiroyuki Nagase
Arerugi = [Allergy]|March 18, 2015
[Current status and perspective of molecular-targeted therapy in asthma]Hiroyuki Nagase
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 2015
[The role of fractional nitric oxide in exhaled breath (FeNO) in clinical practice of asthma]Hiroyuki Nagase
Allergology International : Official Journal of the Japanese Society of Allergology|January 4, 2026
Clinical remission in asthma and related diseases: Current landscape and future perspectivesHiroyuki Nagase
Arerugi = [Allergy]|April 9, 2025
[GUIDELINES FOR MOLECULAR TARGETED THERAPY IN COMPREHENSIVE ALLERGY PRACTICE 2025]Hiroyuki Nagase
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Drug-induced interstitial lung disease]Ken Ohta, Hiroyuki Nagase
Arerugi = [Allergy]|December 21, 2022
[BIOLOGICS AND BRONCHIAL THERMOPLASTY FOR THE TREATMENT OF SEVERE ASTHMA]Hiroyuki Nagase, Motoyasu Iikura
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Asia Pacific Allergy|May 16, 2020
Preface to the Proceedings of the 33rd Workshop on Eosinophils in Allergy and Related Diseases 2019 (WEA 2019)Hiroyuki Nagase
Allergology International : Official Journal of the Japanese Society of Allergology|January 21, 2023
Rapid progress in molecular targeted therapy for allergic diseasesHiroyuki Nagase
Arerugi = [Allergy]|May 21, 2019
[MOLECULAR TARGETED THERAPY FOR ASTHMA: NON-TYPE 2 INFLAMMATION AND TOLL-LIKE RECEPTOR SIGNALING]Hiroyuki Nagase
Allergology International : Official Journal of the Japanese Society of Allergology|March 18, 2019
Severe asthma in JapanHiroyuki Nagase
Arerugi = [Allergy]|March 18, 2015
[Current status and perspective of molecular-targeted therapy in asthma]Hiroyuki Nagase
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 1, 2015
[The role of fractional nitric oxide in exhaled breath (FeNO) in clinical practice of asthma]Hiroyuki Nagase
Allergology International : Official Journal of the Japanese Society of Allergology|January 4, 2026
Clinical remission in asthma and related diseases: Current landscape and future perspectivesHiroyuki Nagase
Arerugi = [Allergy]|April 9, 2025
[GUIDELINES FOR MOLECULAR TARGETED THERAPY IN COMPREHENSIVE ALLERGY PRACTICE 2025]Hiroyuki Nagase
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Drug-induced interstitial lung disease]Ken Ohta, Hiroyuki Nagase
Arerugi = [Allergy]|December 21, 2022
[BIOLOGICS AND BRONCHIAL THERMOPLASTY FOR THE TREATMENT OF SEVERE ASTHMA]Hiroyuki Nagase, Motoyasu Iikura
Pageof 14